Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.88
-0.07 (-0.70%)
Nov 20, 2026, 4:00 PM EST - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $832.5 million as of November 20, 2026. It is the 10,496th most valuable company in the world and the 2,281st biggest in the United States. Its market cap has increased by 77.82% in one year.
Market Cap
832.50M
Enterprise Value
1.04B
1-Year Change
77.82%
Global Rank
Country Rank
#2,281 United States
Category
ChartMarket Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $832.50M, an increase of 16.68%. That is a compound annual growth rate of 2.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 681.32M | 36.73% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IRADIMED CORPORATION | 1.07B |
| Integra LifeSciences Holdings | 1.05B |
| SI-BONE | 1.04B |
| CeriBell | 1.01B |
| AdaptHealth | 1.01B |
| Artivion | 891.39M |
| OrthoPediatrics | 820.13M |
| Beta Bionics | 800.28M |